Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Archives of Internal Medicine|November 30, 2011
Chronic disease management for tobacco dependence: a randomized, controlled trialAnne M Joseph, Steven S Fu, Bruce Lindgren, et al.
Chemical Research in Toxicology|December 21, 2012
Analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB)-releasing DNA adducts in human exfoliated oral mucosa cells by liquid chromatography-electrospray ionization-tandem mass spectrometryIrina Stepanov, John Muzic, Chap T Le, et al.
Drug and Alcohol Dependence|May 19, 2018
Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluationsRachel N Cassidy, Suzanne M Colby, Jennifer W Tidey, et al.
American Journal of Health Promotion : AJHP|August 27, 2013
A pilot study of concurrent lead and cotinine screening for childhood tobacco smoke exposure: effect on parental smokingAnne Joseph, Sharon Murphy, Janet Thomas, et al.
Head & Neck|July 19, 2012
Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control studySamir S Khariwala, Steven G Carmella, Irina Stepanov, et al.
Addiction (Abingdon, England)|September 16, 2010
Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependenceEric O Johnson, Li-Shiun Chen, Naomi Breslau, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 22, 2016
2-Phenethyl Isothiocyanate, Glutathione S-transferase M1 and T1 Polymorphisms, and Detoxification of Volatile Organic Carcinogens and Toxicants in Tobacco SmokeJian-Min Yuan, Sharon E Murphy, Irina Stepanov, et al.
Cancer Research|November 18, 2008
Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamineLoïc Le Marchand, Kiersten S Derby, Sharon E Murphy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2009
Methods used in internal industry clinical trials to assess tobacco risk reductionVaughan W Rees, Jennifer M Kreslake, Richard J O'Connor, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 3, 2018
Age Moderates Smokers' Subjective Response to Very-Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled TrialRachel N Cassidy, Jennifer W Tidey, Qing Cao, et al.
Pageof 15